TNX-801 is a single-dose, live virus vaccine in development to protect against mpox and smallpox TNX-801 protects ...

The FDA has approved a new freeze-dried formulation of Jynneos (smallpox and mpox vaccine, live, non-replicating).

The MVA-BN vaccine showed an overall effectiveness of 57.8% (95% CI, 11.8-83.0) in reducing mpox cases at 14 days or longer after the first dose; however, the effectiveness was lower in people ...

The freeze-dried formulation provides flexibility with regard to storage and shelf life. The Food and Drug Administration (FDA) has approved a new freeze-dried formulation of Jynneos ® (smallpox ...

The US Food and Drug Administration (FDA) has approved the freeze-dried formulation of Bavarian Nordic’s smallpox and mpox vaccine in a move expected to provide flexibility in stockpiling the jab.

But in 1796, Edward Jenner created the smallpox vaccine — the first successful vaccine to be developed. Today, thanks to the power of that vaccine, investments, action, and advocacy, smallpox was ...

Tonix Pharmaceuticals (TNXP) presented data in an oral presentation at the World Vaccine Congress Washington 2025, held April 21-24, 2025, in ...

Denmark's Bavarian Nordic (BAVA.CO), opens new tab said on Monday the U.S. Food and Drug Administration has approved a freeze-dried formulation of its mpox and smallpox vaccine. The company said ...

Most people in the U.S. have received vaccines to protect against infectious diseases. A vaccine against smallpox led to the ...

Since 2003, Bavarian Nordic has worked with the U.S. government on the development, manufacturing and supply of a non-replicating smallpox vaccine to ensure all populations can be protected from ...

And as an aside, is my ancient smallpox vaccination of 1952 still protecting me? What about my equally ancient (circa 1962) polio vaccine? -- C.C. ANSWER: At the time of this writing, the 2024 ...